Goriki Yuhei, Tanaka Atsushi, Nishihira Kensaku, Kuriyama Nehiro, Shibata Yoshisato, Node Koichi
Department of Cardiovascular Medicine, National Hospital Organization Ureshino Medical Center, Saga, Japan.
Department of Cardiovascular Medicine, Saga University, Saga, Japan.
JACC Asia. 2021 Oct 26;1(3):372-381. doi: 10.1016/j.jacasi.2021.07.013. eCollection 2021 Dec.
Development of acute kidney injury (AKI) is associated with poor prognosis in patients with ST-segment elevation myocardial infarction (STEMI).
This study sought to investigate whether a combination of pre-procedural blood tests could predict the incidence of AKI in patients with STEMI.
A total of 908 consecutive Japanese patients with STEMI who underwent primary percutaneous coronary intervention within 48 hours of symptom onset were recruited and divided into derivation (n = 617) and validation (n = 291) cohorts. A risk score model was created based on a combination of parameters assessed on routine blood tests on admission.
In the derivation cohort, multivariate analysis showed that the following 4 variables were significantly associated with AKI: blood sugar ≥200 mg/dL (odds ratio [OR]: 2.07), high-sensitivity troponin I >1.6 ng/mL (upper limit of normal ×50) (OR: 2.43), albumin ≤3.5 mg/dL (OR: 2.85), and estimated glomerular filtration rate <45 mL/min/1.73 m (OR: 2.64). Zero to 4 points were given according to the number of those factors. Incremental risk scores were significantly associated with a higher incidence of AKI in both cohorts ( < 0.001). Receiver-operating characteristic curve analysis of risk models showed adequate discrimination between patients with and without AKI (derivation cohort, area under the curve: 0.754; 95% confidence interval: 0.733-0.846; validation cohort, area under the curve: 0.754; 95% confidence interval: 0.644-0.839).
Our novel laboratory-based model might be useful for early prediction of the post-procedural risk of AKI in patients with STEMI.
急性肾损伤(AKI)的发生与ST段抬高型心肌梗死(STEMI)患者的不良预后相关。
本研究旨在探讨术前血液检查组合能否预测STEMI患者AKI的发生率。
连续纳入908例症状发作后48小时内接受直接经皮冠状动脉介入治疗的日本STEMI患者,并分为推导队列(n = 617)和验证队列(n = 291)。基于入院时常规血液检查评估的参数组合创建风险评分模型。
在推导队列中,多变量分析显示以下4个变量与AKI显著相关:血糖≥200 mg/dL(比值比[OR]:2.07)、高敏肌钙蛋白I>1.6 ng/mL(正常上限×50)(OR:2.43)、白蛋白≤3.5 mg/dL(OR:2.85)和估计肾小球滤过率<45 mL/min/1.73 m²(OR:2.64)。根据这些因素的数量给予0至4分。两个队列中,递增的风险评分均与AKI的较高发生率显著相关(P<0.001)。风险模型的受试者工作特征曲线分析显示,在有和没有AKI的患者之间有足够的区分度(推导队列,曲线下面积:0.754;95%置信区间:0.733 - 0.846;验证队列,曲线下面积:0.754;95%置信区间:0.644 - 0.839)。
我们基于实验室的新型模型可能有助于早期预测STEMI患者术后发生AKI的风险。